Dongliang Gong , Qilin Zhai , Minghu Wu, Xingguang Tao, Fuyong Wang
{"title":"海藻酸-丝素复合水凝胶促进大鼠股骨远端骨缺损修复","authors":"Dongliang Gong , Qilin Zhai , Minghu Wu, Xingguang Tao, Fuyong Wang","doi":"10.1016/j.intimp.2025.114973","DOIUrl":null,"url":null,"abstract":"<div><div>Bone defects, especially those complicated by the inflammatory and immune responses following biomaterial implantation, remain a major challenge in bone regeneration. In this study, we developed Alginate-Silk Fibroin-Graphene Oxide Composite (Alg/SF/GO) hydrogels anchored on the Alg-Tyramine framework, employing HRP/H<sub>2</sub>O<sub>2</sub>-mediated enzyme crosslinking. These hydrogels demonstrated excellent durability and mechanical properties, along with controllable degradation behavior upon the release of silk fibroin and GO. The Alg/SF/GO hydrogels substantially enhanced osteogenic differentiation and mineralization, while also promoting M2 macrophage polarization and migration <em>via</em> the NF-κB and MAPK pathways. The M2 macrophage polarization induced by these hydrogels facilitated the osteogenic differentiation of bone marrow mesenchymal stem cells (BMSCs) through cytokine secretion. Both <em>in vitro</em> and <em>in vivo</em> experiments showed that Alg/SF/GO hydrogels promoted macrophage infiltration into surrounding tissues, reducing inflammation and fibrous capsule thickening. Ultimately, injecting BMSCs with Alg/SF/GO hydrogels successfully repaired distal femoral defects in rats. This bone-healing biomaterial shows promising potential, particularly for treating irregular bone defects.</div></div>","PeriodicalId":13859,"journal":{"name":"International immunopharmacology","volume":"161 ","pages":"Article 114973"},"PeriodicalIF":4.7000,"publicationDate":"2025-06-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Promotion of rat femoral distal bone defect repair using alginate-silk fibroin composite hydrogel\",\"authors\":\"Dongliang Gong , Qilin Zhai , Minghu Wu, Xingguang Tao, Fuyong Wang\",\"doi\":\"10.1016/j.intimp.2025.114973\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Bone defects, especially those complicated by the inflammatory and immune responses following biomaterial implantation, remain a major challenge in bone regeneration. In this study, we developed Alginate-Silk Fibroin-Graphene Oxide Composite (Alg/SF/GO) hydrogels anchored on the Alg-Tyramine framework, employing HRP/H<sub>2</sub>O<sub>2</sub>-mediated enzyme crosslinking. These hydrogels demonstrated excellent durability and mechanical properties, along with controllable degradation behavior upon the release of silk fibroin and GO. The Alg/SF/GO hydrogels substantially enhanced osteogenic differentiation and mineralization, while also promoting M2 macrophage polarization and migration <em>via</em> the NF-κB and MAPK pathways. The M2 macrophage polarization induced by these hydrogels facilitated the osteogenic differentiation of bone marrow mesenchymal stem cells (BMSCs) through cytokine secretion. Both <em>in vitro</em> and <em>in vivo</em> experiments showed that Alg/SF/GO hydrogels promoted macrophage infiltration into surrounding tissues, reducing inflammation and fibrous capsule thickening. Ultimately, injecting BMSCs with Alg/SF/GO hydrogels successfully repaired distal femoral defects in rats. This bone-healing biomaterial shows promising potential, particularly for treating irregular bone defects.</div></div>\",\"PeriodicalId\":13859,\"journal\":{\"name\":\"International immunopharmacology\",\"volume\":\"161 \",\"pages\":\"Article 114973\"},\"PeriodicalIF\":4.7000,\"publicationDate\":\"2025-06-06\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International immunopharmacology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1567576925009634\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"IMMUNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International immunopharmacology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1567576925009634","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
Promotion of rat femoral distal bone defect repair using alginate-silk fibroin composite hydrogel
Bone defects, especially those complicated by the inflammatory and immune responses following biomaterial implantation, remain a major challenge in bone regeneration. In this study, we developed Alginate-Silk Fibroin-Graphene Oxide Composite (Alg/SF/GO) hydrogels anchored on the Alg-Tyramine framework, employing HRP/H2O2-mediated enzyme crosslinking. These hydrogels demonstrated excellent durability and mechanical properties, along with controllable degradation behavior upon the release of silk fibroin and GO. The Alg/SF/GO hydrogels substantially enhanced osteogenic differentiation and mineralization, while also promoting M2 macrophage polarization and migration via the NF-κB and MAPK pathways. The M2 macrophage polarization induced by these hydrogels facilitated the osteogenic differentiation of bone marrow mesenchymal stem cells (BMSCs) through cytokine secretion. Both in vitro and in vivo experiments showed that Alg/SF/GO hydrogels promoted macrophage infiltration into surrounding tissues, reducing inflammation and fibrous capsule thickening. Ultimately, injecting BMSCs with Alg/SF/GO hydrogels successfully repaired distal femoral defects in rats. This bone-healing biomaterial shows promising potential, particularly for treating irregular bone defects.
期刊介绍:
International Immunopharmacology is the primary vehicle for the publication of original research papers pertinent to the overlapping areas of immunology, pharmacology, cytokine biology, immunotherapy, immunopathology and immunotoxicology. Review articles that encompass these subjects are also welcome.
The subject material appropriate for submission includes:
• Clinical studies employing immunotherapy of any type including the use of: bacterial and chemical agents; thymic hormones, interferon, lymphokines, etc., in transplantation and diseases such as cancer, immunodeficiency, chronic infection and allergic, inflammatory or autoimmune disorders.
• Studies on the mechanisms of action of these agents for specific parameters of immune competence as well as the overall clinical state.
• Pre-clinical animal studies and in vitro studies on mechanisms of action with immunopotentiators, immunomodulators, immunoadjuvants and other pharmacological agents active on cells participating in immune or allergic responses.
• Pharmacological compounds, microbial products and toxicological agents that affect the lymphoid system, and their mechanisms of action.
• Agents that activate genes or modify transcription and translation within the immune response.
• Substances activated, generated, or released through immunologic or related pathways that are pharmacologically active.
• Production, function and regulation of cytokines and their receptors.
• Classical pharmacological studies on the effects of chemokines and bioactive factors released during immunological reactions.